1. bookVolume 24 (2016): Issue 3 (September 2016)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Thrombophilia genetic testing in Romanian young women with acute thrombotic events: role of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and A1298C polymorphisms / Evaluarea genetică a trombofiliilor la femei tinere din România cu evenimente acute trombotice: rolul Factorului V Leiden, Protrombinei G20210A, polimorfismelor MTHFR C677T și A1298C

Published Online: 15 Oct 2016
Volume & Issue: Volume 24 (2016) - Issue 3 (September 2016)
Page range: 291 - 305
Received: 13 Jun 2016
Accepted: 05 Sep 2016
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Objective: The present case-control study aimed at evaluating the contribution of thrombophilic polymorphisms to acute venous (VTE) as well as arterial thrombotic events (ATE) in a population of young women with few traditional thrombotic factors (CVRF).

Methods: We consecutively enrolled patients under 45 years of age, with less than 3 CVRF, evaluated for VTE or ATE, women and men as a comparator. The control group consisted of healthy young women. A thrombophilia panel and genetic testing for Factor V Leiden (FVL), G20210A Prothrombin and MTHFR polimorphisms were done.

Results: A total of 323 persons were enrolled: 71 women and 121 men with thromboembolic events, and 131 healthy female as controls. Hyperhomocysteinemia was more frequent in ATE (30.4%) than VTE female patients (6.25%), p<0.01. Genetic testing was available in 45 women and 84 men with acute thrombotic events and in all controls. Homozygous FVL was associated with VTE in young women (10.3% vs 0% controls, p<0.01). Prothrombin G20210A polymorphism had the lowest prevalence – 5.4% and only heterozygosity was found. MTHFR C677T heterozygosity showed no significant difference between women patients and controls (62.2 % vs 43.5% respectively, p=0.1). The homozygous status, less frequent (6.6%), was not associated with ATE or VTE. Homozygous MTHFR A1298C was associated with VTE in women (17.2% patients vs 4.5% controls, OR 4.34, p 0.02, CI 1.22-15.3).

Conclusion: In young women with few CVRF, mild hyperhomocysteinemia, homozygosity for FVL and for MTHFR A1298C polymorphisms increase the risk for VTE but not ATE. MTHFR polymorphisms are found with increased frequency in both healthy persons and patients therefore, their significance as an important thrombotic risk modifier remains unclear.

Keywords

1. Spencer FA, Kroll A, Lessard D, Emery C, Glushchenko AV, Pacifico L, et al. Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study. J. Thromb. Thrombolysis. 2012;33(3):211-7. DOI: 10.1007/s11239-011-0670-x.10.1007/s11239-011-0670-x22261699Search in Google Scholar

2. Ng KW, Loh PK, Sharma VK. Role of investigating thrombophilic disorders in young stroke. Stroke research and treatment. 2011;2011.10.4061/2011/670138303879621331344Search in Google Scholar

3. Yokus O, Albayrak M, Balcik OS, Ceran F, Dagdas S, Yilmaz M, et al. Risk factors for thrombophilia in young adults presenting with thrombosis. Int. J. Hematol. 2009;90(5):583-90. DOI: 10.1007/s12185-009-0447-6.10.1007/s12185-009-0447-619937485Search in Google Scholar

4. Jadaon MM. Epidemiology of activated protein C resistance and Factor V Leiden mutation in the Mediterranean Region. Mediterr. J. Hematol. Infect. Dis. 2011;3:e2011037. DOI: 10.4084/mjhid.2011.037 DOI: 10.4084/mjhid.2011.054.10.4084/mjhid.2011.037Search in Google Scholar

5. Jadaon MM. Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region. Mediterr.Search in Google Scholar

J. Hematol. Infect. Dis. 2011;3(1):e2011054. DOI: 10.4084/mjhid.2011.037 DOI: 10.4084/mjhid.2011.054.10.4084/mjhid.2011.037Search in Google Scholar

6. Prandoni P. Links between arterial and venous disease. J. Intern. Med. 2007;262(3):341-50. DOI: 10.1111/j.1365-2796.2007.01815.x.10.1111/j.1365-2796.2007.01815.x17697155Search in Google Scholar

7. Prandoni P. Venous and arterial thrombosis: Two aspects of the same disease? Clin. Epidemiol. 2009;1:1. DOI: 10.1016/j.ejim.2009.02.001 DOI: 10.2147/clep. s4780.10.1016/j.ejim.2009.02.00119782933Search in Google Scholar

8. Collaboration HS. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288(16):2015-22. DOI: 10.1001/ jama.288.16.2015.10.1001/jama.288.16.201512387654Search in Google Scholar

9. Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch. Pathol. Lab. Med. 2007;131(6):872-84.Search in Google Scholar

10. Trenor CC, Chung RJ, Michelson AD, Neufeld EJ, Gordon CM, Laufer MR, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347-57. DOI: 10.1542/ peds.2010-2221.10.1542/peds.2010-2221302541721199853Search in Google Scholar

11. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, et al. Clinical guidelines for testing for heritable thrombophilia. Br. J. Haematol. 2010;149(2):209-20. DOI: 10.1111/j.1365-2141.2009.08022.x.10.1111/j.1365-2141.2009.08022.x20128794Search in Google Scholar

12. Wu O, Robertson L, Twaddle S, Lowe G, Clark P, Greaves M, et al. Screening for thrombophilia in highrisk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. 2006.10.3310/hta1011016595080Search in Google Scholar

13. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64-7. DOI: 10.1038/369064a0.10.1038/369064a08164741Search in Google Scholar

14. Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, et al. The heterozygous 20210G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler. Thromb. Vasc. Biol. 1997;17(11):2418-22. DOI: 10.1161/01.ATV.17.11.2418.10.1161/01.ATV.17.11.2418Search in Google Scholar

15. A ZC, Yang Y, Zhang SZ, Li N, Zhang W. Single nucleotide polymorphism C677T in the methylenetetrahydrofolate reductase gene might be a genetic risk factor for infertility for Chinese men with azoospermia or severe oligozoospermia. Asian J Androl. 2007;9(1):57-62. DOI: 10.1111/j.1745-7262.2007.00225.x.10.1111/j.1745-7262.2007.00225.x16888682Search in Google Scholar

16. Wu J, Li Y-z, Ma H-y, Bai J, Chen F, Fu S-b. Association between single nucleotide polymorphisms of MTHFR gene and susceptibility of psoriasis. Int J Genet. 2007;30(3):173-7.Search in Google Scholar

17. Shaheen K, Alraies MC, Alraiyes AH, Christie R. Factor V Leiden: How great is the risk of venous thromboembolism? Cleve. Clin. J. Med. 2012;79(4):265-72. DOI: 10.3949/ccjm.79a.11072.10.3949/ccjm.79a.1107222473726Search in Google Scholar

18. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular Disease in Women A Statement for Healthcare Professionals From the American Heart Association.Circulation. 1997;96(7):2468-82. DOI: 10.1161/01. CIR.96.7.2468Search in Google Scholar

10. Trenor CC, Chung RJ, Michelson AD, Neufeld EJ, Gordon CM, Laufer MR, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347-57. DOI: 10.1542/ peds.2010-2221.10.1542/peds.2010-2221302541721199853Search in Google Scholar

11. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, et al. Clinical guidelines for testing for heritable thrombophilia. Br. J. Haematol. 2010;149(2):209-20. DOI: 10.1111/j.1365-2141.2009.08022.x.10.1111/j.1365-2141.2009.08022.x20128794Search in Google Scholar

12. Wu O, Robertson L, Twaddle S, Lowe G, Clark P, Greaves M, et al. Screening for thrombophilia in highrisk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. 2006.10.3310/hta10110Search in Google Scholar

13. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64-7. DOI: 10.1038/369064a0.10.1038/369064a0Search in Google Scholar

14. Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, et al. The heterozygous 20210G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler.Thromb. Vasc. Biol. 1997;17(11):2418-22. DOI: 10.1161/01.ATV.17.11.2418.10.1161/01.ATV.17.11.2418Search in Google Scholar

15. A ZC, Yang Y, Zhang SZ, Li N, Zhang W. Single nucleotide polymorphism C677T in the methylenetetrahydrofolate reductase gene might be a genetic risk factor for infertility for Chinese men with azoospermia or severe oligozoospermia. Asian J Androl. 2007;9(1):57-62. DOI: 10.1111/j.1745-7262.2007.00225.x.10.1111/j.1745-7262.2007.00225.x16888682Search in Google Scholar

16. Wu J, Li Y-z, Ma H-y, Bai J, Chen F, Fu S-b. Association between single nucleotide polymorphisms of MTHFR gene and susceptibility of psoriasis. Int J Genet. 2007;30(3):173-7.Search in Google Scholar

17. Shaheen K, Alraies MC, Alraiyes AH, Christie R. Factor V Leiden: How great is the risk of venous thromboembolism? Cleve. Clin. J. Med. 2012;79(4):265-72.DOI: 10.3949/ccjm.79a.11072.10.3949/ccjm.79a.1107222473726Search in Google Scholar

18. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular Disease in Women A Statement for Healthcare Professionals From the American Heart Association. Circulation. 1997;96(7):2468-82. DOI: 10.1161/01. CIR.96.7.2468. Search in Google Scholar

19. Lowe G. Common risk factors for both arterial and venous thrombosis. Br. J. Haematol. 2008;140(5):488-95. DOI: 10.1111/j.1365-2141.2007.06973.x.10.1111/j.1365-2141.2007.06973.x18275426Search in Google Scholar

20. Zoller B, de Frutos PG, Hillarp A, Dahlback B. Thrombophilia as a multigenic disease. Haematologica. 1999;84(1):59-70.Search in Google Scholar

21. Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation. 2008;118(22):2286-97. DOI: 10.1161/CIRCULATIONAHA.108.778837.10.1161/CIRCULATIONAHA.108.77883719029477Search in Google Scholar

22. Otten AM, Maas AH, Ottervanger JP, Kloosterman A, van’t Hof AW, Dambrink JHE, et al. Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age. European Heart Journal: Acute Cardiovascular Care. 2013;2(4):334-41. DOI: 10.1177/2048872612475270.10.1177/2048872612475270382182524338292Search in Google Scholar

23. Yang X-P, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr. Opin. Nephrol. Hypertens. 2011;20(2):133. DOI: 10.1097/ MNH.0b013e3283431921.10.1097/MNH.0b013e3283431921312388421178615Search in Google Scholar

24. Maas A, Appelman Y. Gender differences in coronary heart disease. Neth. Heart J. 2010;18(12):598-603. DOI: 10.1007/s12471-010-0841-y.10.1007/s12471-010-0841-y301860521301622Search in Google Scholar

25. Hanson NQ, Aras O, Yang F, Tsai MY. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin. Chem. 2001;47(4):661-6.Search in Google Scholar

26. de Bree A, Verschuren WM, Bjorke-Monsen AL, van der Put NM, Heil SG, Trijbels FJ, et al. Effect of the methylenetetrahydrofolate reductase 677C-- >T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am. J. Clin. Nutr. 2003;77(3):687-93.Search in Google Scholar

27. Rosendorff A, Dorfman DM. Activated protein C resistance and factor V Leiden. Arch. Pathol. Lab. Med. 2007;131(6):866-71.Search in Google Scholar

28. Djordjevic V, Rakicevic L, Mikovic D, Kovac M, Miljic P, Radojkovic D, et al. Prevalence of factor V leiden, factor V cambridge, factor II G20210A and methylenetetrahydrofolate reductase C677T mutations in healthy and thrombophilic Serbian populations. Acta Haematol. 2004;112(4):227-9. DOI: 10.1159/000081280. 10.1159/00008128015564739Search in Google Scholar

29. Jukić I, Bingulac-Popović J, Đogić V, Babić I, Culej J, Tomičić M, et al. ABO blood groups and genetic risk factors for thrombosis in Croatian population. Croat. Med. J. 2009;50(6):550-8. DOI: 10.3325/ cmj.2009.50.550.10.3325/cmj.2009.50.550280208820017223Search in Google Scholar

30. Stankovics J, Melegh B, Nagy A, Kis A, Molnar J, Losonczy H, et al. [Incidence of factor V G1681A (Leiden) mutation in samplings from the Hungarian population]. Orv. Hetil. 1998;139(19):1161-3.Search in Google Scholar

31. Cushman M, Rosendaal FR, Psaty BM, Cook EF, Valliere J, Kuller LH, et al. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study. Thromb. Haemost. 1998;79(5):912-5.Search in Google Scholar

32. Rosendaal F, Siscovick D, Schwartz S, Beverly R, Psaty B, Longstreth Jr W, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood. 1997;89(8):2817-21.10.1182/blood.V89.8.2817Search in Google Scholar

33. Hotoleanu C, Popp R, Trifa A. Factor V Leiden, prothrombin G20210A and MTHFR C677T mutations in Romanian patients with deep venous thrombosis. HVM Bioflux. 2014;6(1):15-9.Search in Google Scholar

34. Alfirevic Z, Simundic A-M, Nikolac N, Sobocan N, Alfirevic I, Stefanovic M, et al. Frequency of factor II G20210A, factor V Leiden, MTHFR C677T and PAI-1 5G/4G polymorphism in patients with venous thromboembolism: Croatian case-control study. Biochemia Medica. 2010;20(2):229-35. DOI: 10.11613/ BM.2010.028.10.11613/BM.2010.028Search in Google Scholar

35. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999;99(8):999-1004. DOI: 10.1161/01.CIR.99.8.99910.1161/01.CIR.99.8.999Search in Google Scholar

36. Hotoleanu C, Trifa A, Popp R, Fodor D. The Importance of homozygous polymorphisms of methylenetetrahydrofolate reductase gene in romanian patients with idiopathic venous thromboembolism. Balkan medical journal. 2013;30(2):197. DOI: 10.5152/balkanmedj. 2013.7159.Search in Google Scholar

37. Shmeleva VM, Kapustin SI, Papayan LP, Sobczyńska- Malefora A, Harrington DJ, Savidge GF. Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia. Thromb. Res. 2003;111(6):351-6. DOI: 10.1016/j.thromres. 2003.10.004. Search in Google Scholar

38. Nizankowska-Mogilnicka E, Adamek L, Grzanka P, Domagala T, Sanak M, Krzanowski M, et al. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur. Respir. J. 2003;21(1):25-30. DOI: 10.1183/09031936.03.00034302.10.1183/09031936.03.0003430212570104Search in Google Scholar

39. Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR. No association between the common MTHFR 677C→ T polymorphism and venous thrombosis: results from the MEGA study. Arch. Intern. Med. 2007;167(5):497-501.DOI: 10.1001/archinte.167.5.497.10.1001/archinte.167.5.49717353498Search in Google Scholar

40. De Stefano V, Zappacosta B, Persichilli S, Rossi E, Casorelli I, Paciaroni K, et al. Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease. Br. J. Haematol. 1999;106(2):564-8. DOI: 10.1046/j.1365-2141.1999.01613.x. 10.1046/j.1365-2141.1999.01613.x10460623Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo